Screening and mechanistic study of natural compounds that enhance T cell anti-tumor effects post-heat treatment

Following the approval of Chimeric Antigen Receptor T-cell Immunotherapy(CAR-T) in multiple countries, the Food and Drug Administration (FDA) approved tumor-infiltrating lymphocytes (TILs) and T-cell receptor-engineered T cells (TCR-T) treatments this year. The utilization of adoptive immunotherapy...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 16; p. 1537398
Main Authors Wang, Zhaoyi, Diao, Zhongqi, Zhang, Yiyan, Liu, Jiangying, Li, Yeshan, Sun, Zijin, Zhen, Huimin, Wang, Haojia, Yang, Siyun, Wang, Tieshan, Ni, Lei
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.03.2025
Subjects
Online AccessGet full text

Cover

Loading…